CLINICAL RESEARCH AND METHODS2. Menkes JH, Sarnat HB: Child Neurology, Philadelphia,Lippincot Williams & Wilkins, 2006, 7th ed. bddeathdalyestimates.xls.25. Pharoah POD, Platt MJ, Cooke T. The changing13. http://www.who.int/entity/healthinfo/statistics/bodg-Behav Pediatr 2001 ; 22 : 11-18.3. Badawi N, Watson L, Petterson B, Blair E, Slee J, 14. Hermansen MC. Perinatal causes <strong>of</strong> cerebral palsy. panorama <strong>of</strong> cerebral palsy. Arch Dis Child 1996;Haan E et al. What constitutes cerebral palsy? Dev Clin Perinatol 33: 2006.75: F169-F173.Med Child Neurol 1998; 40: 520-527.15. Moster D, Lie RT, Irgens LM, et al. The association 26. Hack M et al. Effect <strong>of</strong> very low-birth-weight and4. # Arpino C, Curatolo P, Stazi MA, Pellegri A, VlahovD. Differing risk factors for cerebral palsy in the palsy: a population-based study in term infants. J age. N Engl J Med 1991;325:231-237.<strong>of</strong> Apgar score with subsequent death and cerebral subnormal head size on cognitive abilities at schoolpresence <strong>of</strong> mental retardation and epilepsy. J Child Pediatr 2001;138:798-803.27. Piecuch RE, et al. Outcome <strong>of</strong> extremely low-birthweightinfants (500 to 999 grams) over a 12-yearsNeurol 1999;14:151-155.16. Nelson KB, Ellenberg JH. Antecedents <strong>of</strong> cerebral5. # Volpe JJ: Hypoxic-ischemic encephalopathy: clinicalaspects. In Volpe JJ (ed): Neurology <strong>of</strong> the New-1986;315-86.28. Hach M, et al. School-age outcomes in childrenpalsy: multivariate analysis <strong>of</strong> risk. N Engl J Med. period. Pediatrics 1997;100:633-639.born, 4rd ed. Philadelphia, WB Saunders,2001,pp 17. Stanley FJ, Blair E: Why have we failed reduce with birth weights under 750 g. N Engl J med314-369.the frequency <strong>of</strong> cerebral palsy? Western AustralianResearch Institute for Children Health - Prin-29. Kolawole TM, Patel PJ, Mahdi AH. Computed tomo-1994;331:753-753.6. McMillan J, Deangelis CD, Feigin RD, et al, Oski’sPediatrics, 3nd ed, Philadelphia, Lippincitt Williams cess Margaret Hospital Subiaco. Med J Austria. graphic (CT) scans in cerebral palsy (CP). Pediatr& Wilkins, 1999, pp 756 - 840.1991;6:623-26.Radiol 1989; 20: 23-27.7. Rudolph AM, Huffman JIE, Rudolph CD: Pediatrics, 18. Robertson CMT, Finer NN. Long-term follow-up <strong>of</strong> 30. Al-Sulaiman A. Electroencephalographic finding inUSA, INC, 1996, pp. 87 - 195.term neonates with perinatal asphyxia. Clin Perinatol1993;20:483-500.funct Neurol 2001; 16; 325-328.children with cerebral palsy; a study <strong>of</strong> 151 patients.8. Day RE: Psychomotor and Intellectual DevelopmentIn: Campbell AGM, Mc Intosh N(ed), FORFAR 19. Sajedi F, Togha M, Karimzadeh P. A survey <strong>of</strong> 200 31. Zafeiriou DI, Kontopoulos EE, Tsikoulas I. Characteristicsand prognosis <strong>of</strong> epilepsy in children with& ARNEIL textbook <strong>of</strong> Pediatrics,5th ed, New York , cases <strong>of</strong> cerebral palsy in welfare and rehabilitationChurchill, 1998, pp 349 - 381.centers <strong>of</strong> Tehran. Saudi J Disabil 2003;9(1):1-7. cerebral palsy. J Child Neurol 1999; 14: 289-294.9. Botos M, Granato G, Gloachin C, Puato ML. Prevalence<strong>of</strong> cerebral palsy in north-east Italy from 1965 tion between acute intrapartum events and cerebral NL: Language abilities following prematurity, periv-20. MacLennan A. A template for defining a causal rela-32. Feldman HM, Janosky JE, Scher MS and Warchamto 1989. Dev Med Child Neurol 1999; 41: 26-39. palsy: international consensus statement. BMJ entricular brain injury, and CP. <strong>Journal</strong>- Common-10. Liu JM, Li S, Lin Q, Li Z . Cerebral palsy in China. Int 1999; 319: 1054-1059.Disorder. 1994;27(2):71-90.J Epidemiol.1999; 28(5): 949-54.21. Kuban KCK, Leviton A. Cerebral palsy. N Engl J 33. Lespargot A, Langevin MF, Muller S, GuillemontS: Swallowing disturbances associated with11. Dite GS, Reddihough DS, Bessell C, Brennecke S, Med 1994; 330: 188-195.Sheedy M. Antenatal and perinatal antecedents <strong>of</strong> 22. Rosenbloom L. Diagnosis and management <strong>of</strong> cerebralpalsy. Arch Dis Child 1995; 72: 350-354.1993;35(4):298-304.drooling in CP children: Dev Med Child Neurol.moderate and severe spastic cerebral palsy. Aust NZ J Obstet Gynaecol 1998; 38: 377-383.23. Al-Sulaiman A, Bademosi OF, Ismail HM et al. 34. Schenk-Rootlieb AJF, van Nieuwenhuzen O, van12. Vohr BR, Cashore WJ, Bigsby R: Stresses and Interventionsin the Neonatal Intensive Care unit In: 2003;8(1):26-29.alence <strong>of</strong> cerebral visual disturbances in childrenCerebral palsy in Saudi children. Neurosciences der Graaf Y, Wittebol-Post D, Willense J. The prev-Levine MD, Carey WB, M.D, Crocker AC: Developmental-Behavioral Pediatrics, 3rd Edition, 1999,W. , academic progress , behavior and self concept at 473-480.24. Rickards AL , Kelly EA, Doyle LW , et al . Cognition with cerebral palsy. Dev Med Child Neurol 1992; 4:B.Saunders Company.14 years <strong>of</strong> very low birth weight children . J DevTable 1: Frequency <strong>of</strong> major symptoms and signs in Iranian Table 2: Frequency <strong>of</strong> main associated factors in Iranian childrenaged 1-6 years with cerebral palsy (N=112)children aged 1-6 years with cerebral palsy (N=112)FrequencyEtiologyMale N=53 Female N=59 Total N(%)Male Female TotalPrenatal & Intra uterineN=53 N=59 N (%)Small for Gestational Age 221638 (33.9)Presenting symptomsIntra Partum Hemorrhage 4610 (8.9)Delayed Milestones 5052 102(91.1)PROM9817 (15.2)Inability to Walk 3128 59 ( 52.7)Multiple pregnancy7411 (9.8)Delayed speech 2125 46 ( 41.1)Breech presentation134 (3.6)Seizure1816 34 (30.4)Preeclampsia314(3.6)Poor head control 1214 26 ( 23.3)Intra Uterine Infection (TORCH) 358(7.1)Physical signsStructural Uterine Abnormality 123(2.7)Motor Weakness 3041 71(63.4)Using Drug5510(8.9)Spasticity3131 62(55.4)Infertility Treatment459(8)Microcephaly2020 40(35.7)Repeated Abortion91019(17)Speech disorders 1720 37(33)Sensory disorder 1011 21(18.8)Perinatal & Early postnatalStrabismus10818(16.1)onsetHearing Loss549(8.9)Low Birth Weight262551 (45.4)Mental Retardation 538(8)Neonatal seizure111728 (25)Preterm delivery251742 (37.5)Depressed Apgar score 252752 (46.4)Table 3: Types <strong>of</strong> Cerebral Palsy in 112 Iranian childrenNICU Admission > 3 days 252247 (42)Meconium-stained Amniotic 246(5.4)TYPEFrequencyfluidN PercentProlong Labor022(1.8)spastic Hemiplegia 41 36.6Diplegia 35 31.3Postnatal onsetSevere hyperbilirubinemia 246(5.3)Quadriplegia 14 12.5Pneumonia type II13821(18.8)non-spastic Hypotonic & Atonic 15 12.5Metabolic Disorder121022(19.6)Attetoid or Dyskinetic 5 4.5Infantile Seizures141226(22.3)Mix 2 1.8Total 112 100Table 4: Frequency <strong>of</strong> birth weight <strong>of</strong> 112 Iranian cerebralpalsy children.Birth Weight FrequencyN Percent> 4000 gm 2 1.82500-4000 gm 59 52.81500-2500 gm 36 32.1
CLINICAL RESEARCH AND METHODSPathophysiology <strong>of</strong> MigraineABSTRACTMigraine is a neurovascular disordercharacterized by a unilateral mild orsevere headache lasting from a fewhours to as long as three days. It hasbeen recently shown in many studiesthat this disorder has a firm andcomplicated genetic background thatexposes individuals to a higher susceptibilityto migraine attacks. Oldtheories used to focus on the vascularchanges and the subsequentblood flow alterations in the brain toexplain the different symptoms occurringduring migraines. New theorieson the other hand are sheddingmore light on the involvement <strong>of</strong> thenervous system in the brain, primarilythe trigeminal nerve in the brainstem, considering it the primarycause for the initiation <strong>of</strong> migraineattacks. Changes in blood vessels inthe brain are believed to be an epiphenomenononly.In this article, the pathophysiology <strong>of</strong>a migraine attack is explained on thebasis <strong>of</strong> the unified theory that triesto integrate all the available scientificdata about migraine.M. Bashir Abiad, BS BiologyPathophysiology <strong>of</strong>migraine:Migraine is best defined as achronic disorder <strong>of</strong> the centralnervous system. It is characterizedby a series <strong>of</strong> events beginningwith the abnormal over-excitement<strong>of</strong> certain nerve cells in the brain.These neurons release a pool <strong>of</strong>chemicals that stimulate the brain’sblood vessels to swell (vasodilation),and create an inflammatory reactionin the affected area. As a result,the person suffers from a severeand pulsating unilateral headache,accompanied by nausea, vomiting,visual and auditory problems, tingling<strong>of</strong> the face and extremities, as well asfatigue, drowsiness and yawning [1] .Migraine attacks may be triggeredby many different factors, includinghormonal changes (observedin menstrual cycles, with oralcontraception or estrogen replacementtherapy, which explains why nearly74% <strong>of</strong> migraine sufferers in theUnited States are females [2] ). Othertriggers involve dietary factors (likechocolate; alcohol; cheese; yoghurt;fermented, decayed or marinatedmeat and anything that may containtyramine, a monoamine which isproduced by the decarboxylation <strong>of</strong>tyrosine during fermentation or decayand that causes the release <strong>of</strong> storedmonoamines (dopamine, epinephrineor norepinephrine) [3] . Changes in sleeppatterns, emotional disturbances(like excitement, fear, anxiety, anger,and stress), allergic reactions, andenvironmental factors (like weatherchanges, bright light, loud noise,certain odors and perfumes) mayalso trigger migraine attacks [4] . Eachperson, with his/her unique geneticbackground, is at a certain threshold<strong>of</strong> neuronal excitability in his/herbrain. In fact, specific allele mutationshave been recently discovered to beinvolved in exposing the individualto higher risks to migraine attacks:four different missense mutations inthe α 1Asubunit <strong>of</strong> the P/Q – type <strong>of</strong>voltage-gated Ca 2+ on chromosome19 affect the release <strong>of</strong> serotonin,a vasoconstrictor, in midbrain [5][6][7] .ATP1A2 gene, found on chromosome1q23, is also linked to migraineattacks. This gene codes for theα 2subunit <strong>of</strong> the Na + /K + ATPase [8] .Moreover, the dopamine D2 receptorgene is found to be responsible als<strong>of</strong>or increasing the susceptibility tomigraine recurrence [9] .When exposed to the migrainetriggers listed above, the ones withlow threshold (i.e. higher susceptibilityto migraine attacks) will experience ashort wave <strong>of</strong> neural depolarizationin the brain due to the initial release<strong>of</strong> potassium and glutamate in theoccipital lobe and then propagatethroughout the whole cortex at aspeed ranging between 3 and 6 mm/min. This wave is followed by a longerone <strong>of</strong> neural depression known ascortical spreading depression, orsimply CSD [1] . These consecutivealterations in the neural activity in thebrain stimulate the vasoconstriction<strong>of</strong> specific blood vessels in thebrainstem. If the decrease in the bloodflow goes below a critical value, thedifferent symptoms observed duringthe aura phase (e.g. blurred vision,weakness, tingling or numbness <strong>of</strong>the face and extremities) may beinitiated [10] .It should be noted that one thirdonly <strong>of</strong> migraine sufferers passthrough the aura symptoms. The resttwo third, despite the electrical wavedisturbances, have what we callmigraine without aura because thedecrease in blood flow in their brainis not so critical [11] . Some studieshave shown that the disruption <strong>of</strong> thenormal electric status <strong>of</strong> the brainmight affect the performance <strong>of</strong> thehypothalamus causing the differentprodromal signs observed severalhours (or even days) before themigraine, like mood disturbances,food cravings, drowsiness, thirst, andyawning [12] .MIDDLE EAST JOURNAL OF FAMILY MEDICINE • VOLUME 6, ISSUE 6 29